122 related articles for article (PubMed ID: 9697825)
1. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.
Allaire E; Hasenstab D; Kenagy RD; Starcher B; Clowes MM; Clowes AW
Circulation; 1998 Jul; 98(3):249-55. PubMed ID: 9697825
[TBL] [Abstract][Full Text] [Related]
2. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.
Allaire E; Forough R; Clowes M; Starcher B; Clowes AW
J Clin Invest; 1998 Oct; 102(7):1413-20. PubMed ID: 9769334
[TBL] [Abstract][Full Text] [Related]
3. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
4. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
Carmeliet P; Moons L; Lijnen R; Baes M; Lemaître V; Tipping P; Drew A; Eeckhout Y; Shapiro S; Lupu F; Collen D
Nat Genet; 1997 Dec; 17(4):439-44. PubMed ID: 9398846
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
7. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation.
Allaire E; Muscatelli-Groux B; Mandet C; Guinault AM; Bruneval P; Desgranges P; Clowes A; Méllière D; Becquemin JP
J Vasc Surg; 2002 Nov; 36(5):1018-26. PubMed ID: 12422114
[TBL] [Abstract][Full Text] [Related]
8. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
10. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
14. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
Ahn MY; Zhang ZG; Tsang W; Chopp M
Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activators in abdominal aortic aneurysmal disease.
Reilly JM
Ann N Y Acad Sci; 1996 Nov; 800():151-6. PubMed ID: 8958990
[TBL] [Abstract][Full Text] [Related]
17. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
[TBL] [Abstract][Full Text] [Related]
19. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the binding of plasminogen activators to plasma membranes from human liver.
Nguyen G; Self SJ; Camani C; Kruithof EK
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):911-5. PubMed ID: 1445249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
